Skip to content


Fetroja, Fetcroja (cefiderocol) is a small molecule pharmaceutical. Cefiderocol was first approved as Fetroja on 2019-11-14. It is used to treat bacterial infections, pyelonephritis, and urinary tract infections in the USA. It has been approved in Europe to treat gram-negative bacterial infections. Fetroja's patents are valid until 2035-09-03 (FDA).
Trade Name Fetcroja
Common Name Cefiderocol
Indication bacterial infections, gram-negative bacterial infections, pyelonephritis, urinary tract infections
Drug Class Cephalosporins
Get full access now